Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, G

Journal title: New England Journal of Medicine

Journal number: 379/15

Journal publisher: Massachusetts Medical Society

Published year: 2018

Published pages: 1403-1415

DOI identifier: 10.1056/NEJMoa1800474

ISSN: 0028-4793